NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/26/2023
Back to search
Official data from USPTO
TAKE2
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
09/26/2023
Trademark type
Word
Nice classes
42, 44
Filing date
06/28/2021
Registration date
09/26/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/26/2023
Last transaction
09/26/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
99
Owner location
Hong Kong, HK
Examiner
NADELMAN, ANDREA KOYNER
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Take2 Health Limited
Representatives
Tama L. Drenski RENNER, KENNER, GREIVE, BOBAK, TAYLOR & WEBER
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
DNA screening for scientific research purposes; providing diagnostic services for others in the fields of scienceproviding reagent sample diagnostic services for scientific research purposes and scientific research related thereto; providing reagent sample testing services for others in the fields of science and scientific research related thereto; computer services in the field of pharmaceutical and health care computer productscomputer diagnostic services and computer graphics services; providing an on-line network environment featuring technology that enables users to storeanalyze and share data in the fields of life science; technical support servicestroubleshooting in the nature of diagnosing problems with medical equipment; consulting services in the field of genetic science and scientific research related thereto; providing temporary use of on-line non-downloadable software for the custom design and ordering of assays and reagents; design and development of computer software for use in analysis of biomolecules relating to diagnosing or screening cancer; design and development of computer software for use in analysis of biomolecules relating to studying genetics and DNA; installation and maintenance of on-line non-downloadable cloud computer software and software databases used in the field of analysis of biomolecules relating to diagnosing or screening cancer; installation and maintenance of on-line non-downloadable cloud computer software and software databases used in the field of analysis of biomolecules relating to studying genetics and DNA; design and development of computer software for use in Software as a Service (SaaS) services for use in genetic and bioinformatics analysis; product development of products used in the fields of scientific and clinical research; product research and development services for others in the field of chemicals and reagents for use as diagnosticsother utilitiesfor use in chemical screening and diagnostic services; product research and development services for others in the field of pharmaceutical and health care products; laboratory research in the field of gene sequencing utilizing testing probes and analytic software; database development services; biotechnology research; scientific research services in the nature of chemical screening analysis for scientific research purposes; product research and development services for others in the field of chemicals and reagents for use as diagnosticstherapeuticsherbicidescytotoxic agentsother utilitiesfor use in chemical screening and diagnostic services for others; product researchdevelopment and design of pharmaceutical and health care products; laboratory analysis in the field of nucleic acids and proteinsamong which the analysis of nucleic acids and proteins for detection purposes and monitoringtesting and approving the quality specification of same; medical and scientific research in the field of cancer detection and treatment
Class 44
Medical services; medical diagnostic testing and reporting services; clinical diagnostic servicespreparingamplifyinglabelingdetectinganalyzing and sequencing nucleic acids and other biological molecules from human beings or animalsall for medical purposes; genetic testing for medical purposes
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/26/2023
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
08/22/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/22/2023
IUCN
NOTICE OF ALLOWANCE CANCELLED
07/18/2023
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
07/18/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/18/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/23/2023
PUBO
PUBLISHED FOR OPPOSITION
05/23/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/03/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/18/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
04/13/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/28/2022
GNSL
LETTER OF SUSPENSION E-MAILED
09/28/2022
CNSL
SUSPENSION LETTER WRITTEN
09/28/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/14/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/14/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/14/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/21/2022
GNRT
NON-FINAL ACTION E-MAILED
03/21/2022
CNRT
NON-FINAL ACTION WRITTEN
03/21/2022
DOCK
ASSIGNED TO EXAMINER
03/18/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/10/2021
NWAP
NEW APPLICATION ENTERED
07/01/2021
Continuous trademark protection
Get notified about every new filing that threatens TAKE2 or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.